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Background: Succinylcholine remains the drug of choice for satisfactory rapid-sequence tracheal intubation.
It is not clear from the literature why the 1 mg/kg dose of succinylcholine has been traditionally used. The
effective dose (ED95) of succinylcholine is less than 0.3 mg/kg. The dose of 1 mg/kg represents 3.5 to 4 times
the ED95.
Objectives: To compare the effect of the traditionally used 1 mg/kg of succinylcholine with lower doses of
0.6 mg/kg and 0.45 mg/kg on intubation condition regarding the onset time, duration of action, duration of
abdominal fasciculation, and the intubation grading.
Methods: This retrospective comparative study was carried into three groups of ASA III & IV (American
Society of Anesthesiologist’s Physical Status III and IV) non-prepared emergency patients who were intubated
at emergency department of Hamad General Hospital, Doha, Qatar during January 1st 2007 to August 31,
2010. The Institutional Research Board (IRB) approval was obtained. This study was limited to 88 patients
who received fentanyl 1 mg/kg followed by etomidate 0.3 mg/kg intravenously as induction agents and
succinylcholine as a muscle relaxant agent in doses of 0.45 mg/kg, 0.6 mg/kg, or 1 mg/kg.
Results: Increasing the succinylcholine dosage shortened the onset time, prolonged the duration of action, and
prolonged the duration of abdominal fasciculation significantly (PB.001). Tracheal intubation was 100%
successful in the three groups of patients.
Conclusion: Succinylcholine dose of 0.45 mg/kg provides an optimal intubation condition in ASA III & IV
emergency non-prepared patients. Duration of action of succinylcholine is dose dependent; reducing the dose
allows a more rapid return of spontaneous respiration and airway reflexes.
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S
uccinylcholine remains the drug of choice for
satisfactory rapid-sequence tracheal intubation. It
was first described 50 years ago (1, 2). In early
studies, doses averaging less than 0.5 mg/kg were usually
administered (total 1050 mg). Maybe as a consequence,
succinylcholine in 1 mg/kg has been established as the
usual dose for intubation (3). It is not clear from the
literature why 1 mg/kg dose of succinylcholine has been
traditionally used for tracheal intubation. Spontaneous
recovery from the induced apnea with succinylcholine in
1 mg/kg may not develop fast enough to prevent hemo-
globin desaturation in patients with unassisted ventilation
(4). That will be clinically significant as a life threatening
hemoglobin desaturation in an unanticipated difficult
airway. Smaller doses of succinylcholine may shorten this
time of vulnerability (5).
The effective dose (ED95) of succinylcholine is less
than 0.3 mg/kg (6, 7). A dose of 1 mg/kg represents 3.5 to
4 times the ED95. In succinylcholine, as a depolarizing
neuromuscular blocker, doses equivalent to double the
ED95 are generally considered to be the appropriate dose
for intubation (8). Doses only 1.5 times the ED95 can
provide satisfactory conditions for tracheal intubations,
smaller dose as 0.4 mg/kg might also provide clinical
acceptance (7). Naguib et al. strongly supports this hy-
pothesis (8). They found in ASA I & II patients
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and II) that 0.56 mg/kg succinylcholine was sufficient to
provide acceptable (excellent or good) intubating condi-
tions at 60 sec in 95% of patients; where doses as low as
0.3 mg/kg produced the same acceptable intubating
conditions in 92% of patients (8).
The possibility of an earlier return of neuromuscular
function following low-dose succinylcholine has much to
recommend it especially in cases with unanticipated
difficult airways or high risk conditions (913). All
studies with the information about using smaller doses
of succinylcholine (less than the conventional dose
1 mg/kg) were dealt with the induction for intubation in
elective procedures or simulated rapid sequence induction
in well-prepared ASA I & II patients (14). No studies at
all were applied to the high risk ASA EIII & EIV non-
prepared patients where the letter E indicates an emer-
gency condition.
Materials and methods
According to the succinylcholine injected dose, this
retrospective comparative study was carried into three
groups of ASA III & IV non-prepared emergency
patients who were intubated at the emergency department
of Hamad General Hospital, Doha, Qatar in a period
from January 1st 2007 to August 31, 2010. The Institu-
tional Research Board (IRB) approval was obtained.
Many induction agents in different doses were used in
intubation during this period, our study was limited to
only 88 patients who received fentanyl 1 mg/kg followed
by etomidate 0.3 mg/kg intravenously as induction agents
and succinylcholine as a muscle relaxant agent. Accord-
ing to the injected succinylcholine dose, patients were
allocated into three groups. Group 1 includes 26 patients
who received a dose of 0.45 mg/kg, group 2 includes
27 patients who received a dose of 0.6 mg/kg, and group 3
includes 35 patients who received a dose of 1 mg/kg.
Tracheal intubation was carried out by the assigned
anesthesiologist in the emergency department.
Records were reviewed for the duration of abdominal
fasciculation (time from start of abdominal contractions
to total abdominal flaccidity), onset time (time from drug
injection to total anterior wall flaccidity), and the
duration of action (time from the drug onset of action
to resumption of breathing) (11). Intubation condition
was graded based on the accepted criteria for good
clinical research practice (Table 1) (8, 11, 13).
During the period of this retrospective study, intuba-
tion was carried out by different anesthetists with
different inductive agents in different doses at the
emergency department. The study was limited only to
those who received the previously mentioned drugs in its
previously described doses, which limits the total number
to 88. Applied exclusion criteria included (a) patients
with extremity of ages (less than 15 and more than
65 years), (b) patients with body mass indices more
than 28 kg/m
2, (c) pregnant women, (d) patients in
arrhythmias, and (e) patients with an abnormal airway
examination.
Statistical analysis
Descriptive statistics have been performed in the form of
mean and standard deviation for continuous variables
and frequency with a percentage performed for catego-
rical variables. One way analysis of variance (ANOVA)
with post-hoc analysis (Bonferroni Test) has been applied
to see significance among groups for continuous variables
and the chi-square test was performed for categorical
variables. P-value less than .05 (two-tailed) has been
considered as statistical significance level. SPSS 17.0
Table 1. Criteria for grading tracheal intubation conditions (8, 11, 13)
Intubating grading
Variables excellent good poor failed
Laryngoscopy Easy Fair Difficult Inapplicable
Vocal cords
Movements None Moving Closing Closed
Position Abducted Intermediate Closed Closed
Reaction to intubation
Coughing None Slight Vigorous Persistent
Limbs movements None Slight Sustained (B10 s) Sustained ( 10 s)
Intubation conditions: Excellent: all variables are excellent; Good: all variables are excellent or good; Poor: the presence of one or more
variables graded as poor; Failed: inapplicable laryngoscopy graded as failed.
Laryngoscopy: Easy: jaw relaxed, no resistance to blade during laryngoscopy; Fair: jaw not fully relaxed, slight resistance to blade;
Difficult: poor jaw relaxation, active resistance by the patient; Failed: no jaw relaxation, extensive resistance by the patient.
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2
(page number not for citation purpose)
Citation: Libyan J Med 2011, 6: 7041 - DOI: 10.3402/ljm.v6i0.7041(Statistical Package for the Social Sciences) was used for
statistical analysis for the study.
Results
After application of the exclusion criteria, the total
number of patients was limited to 60 patients. There
were no significant differences among the three groups
regarding baseline demographic data, including age, sex,
height, weight, and ASA physical status (Table 2).
After doses 0.45mg/kg (group 1), 0.6mg/kg (group 2),
and 1 mg/kg (group 3), the onset time was 6592.5 sec,
5592.5 sec, and 44.992.5 sec, while the duration of
action was 590.1 min, 6.490.8 min, and 12.591.3 min,
respectively. Increasing the succinylcholine dose shor-
tened the onset time and prolonged the duration of action
significantly (PB.001) (Table 3).
Duration of abdominal fasciculation revealed signifi-
cant shortening with less than 5 sec in 95% of patients
(group 1), 60% (group 2), and only 16% (group 3).
Prolonged fasciculation time more than 10 sec was not
observed in group 1 but was reported in 15% of group 2,
and 47% in group 3. Increasing the succinylcholine dose
prolonged the duration of abdominal fasciculation sig-
nificantly (PB.001) (Table 3).
There were dose dependant significant differences
among the different doses of succinylcholine. High doses
result in fast onset of action (PB.001), prolong the
duration of action (PB.001), and prolonged abdominal
fasciculation duration (PB.001).
Tracheal intubation was successful (equals to accepted)
in all patients (Table 4). The incidence of excellent
intubating conditions was increased by increasing the
drug dose in the form of 85.7%, 90%, 94.7% for doses
0.45 mg/kg, 0.6 mg/kg, and 1 mg/kg, respectively.
There were no significant differences between the three
groups in laryngoscopy, vocal cords (movements or
position), and reaction to intubation (coughing or limb
movements) (P.637). The incidence of aspiration was
none in this study.
Discussion
Although the use of succinylcholine was markedly
reduced over the last few years with the use of the new
short acting non-depolarizing muscle relaxants, succinyl-
choline still has the upper hand as the muscle relaxant of
choice for endotracheal intubation in emergency patients.
The aim of this retrospective study is to investigate if
small doses of succinylcholine (less than 1 mg/kg) can
produce satisfactory intubation for rapid sequence en-
dotracheal intubation in non-prepared patients and if it is
associated with a shorter recovery time that might avoid
critical oxygen desaturation especially when not able to
intubate ventilated patients?
The nature of patients subjected for intubation in the
study in both trauma and medical resuscitative rooms in
emergency department includes unknown past and
current medical history, unknown anesthesia history,
full stomach, and critically ill status (ASA III & IV).
All those factors indicate the reduction of fentanyl dose
to 1 mcg /kg, the use of etomidate in 0.3 mg/kg body
weight to provide a minimum effect in the hemodynamic
stability of the patients and avoid any synergistic effect of
both agents with the succinylcholine in the intubation
conditions (14, 15). The dose 1 mg/kg represents more
than triple ED95 of succinylcholine.
Many inductive agents in different doses were used for
intubation at the emergency department during the
period of the study. The study was limited only to
patients who received fentanyl in 1 mg/kg followed by
Table 2. Demographic data (SD based)
Succinylcholine dose
Variables
Group 1
0.45 mg/kg
Group 2
0.6 mg/kg
Group 3
1 mg/kg P-value
Age (year) 37.397.9 38.6915.9 36.6913.4 0.086
Sex
Men 17 (81%) 19 (95%) 19 (100%) 0.075
Women 4 (19%) 1 (5%) 0 (0%)
Weight (kg) 69.997.5 70.5914.2 72.4919.8 0.862
Height (cm) 166.296.1 167.397.5 172.4911.8 0.069
Body mass index (kg/m2) 25.191.9 24.893.4 23.993.8 0.452
ASA E
III 4 (19%) 9 (45%) 8 (42.1%)
IV 17 (81%) 11 (55%) 11 (57.9%) 0.161
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followed by the succinylcholine in the subjective doses of
the study: 0.45 mg/kg, 0.6 mg/kg, and 1mg/kg. The total
number was limited to 88 patients, and after application
of other exclusion criteria the number was restricted to
60. Exclusion criteria included (a) patients with extremity
of ages (less than 15 and more than 65 years), (b) patients
with body mass indices more than 28 kg/m
2, (c) pregnant
women, (d) patients in arrhythmias, and (e) patients with
an abnormal airway examination.
The assessment of the neuromuscular response of the
depolarizing muscle relaxant through the twitches of the
adductor policies is not a very useful measure for
evaluating the neuromuscular block at the laryngeal,
diaphragm, and masseter muscles. The return of the
diaphragm muscle activity (re-polarizationend of pa-
ralytic effectresumption of breathing) was 2 min earlier
than the hand adductor policies muscle after succinylcho-
line in many studies (16, 17). For the above mentioned
reasons and because these were emergency patients,
peripheral nerve stimulation was not used. The onset
time, the duration of action, and duration of abdominal
fasciculation were obtained from records to anterior
abdominal wall inspection during induction and recovery
from the drug effect.
There were no significant differences among the three
groups regarding baseline demographic distribution in-
cluding age, gender (men/women), weight, height, and
ASAphysicalstatus(P.161)(Table2).Afterintravenous
administration of 0.45 mg/kg, 0.6 mg/kg, and 1 mg/kg
succinylcholine (group 1, 2, and 3), the onset time was
6592.5 sec, 5592.5 sec, and 44.991.3 sec, respectively
(Table 3), which was nearly similar to the results obtained
by El-Orbany et al., results that were 67.391 sec, 559
11 sec, and 5295 sec, respectively (11). Increasing the
doseofsuccinylcholineallows afasteronset ofaction (PB
.001) (Table 3). No data is available about the risk of
aspiration if the tube is introduced into the trachea at
6090 sec instead of the usually advocated 60 sec (8). The
incidence of aspiration in this study was none. Comparing
groups1,2,and3,themeandurationsofapneawere5 min,
6.4 min, and 12.5 min, respectively (PB.001) (Table 3).
Reducing the dose of succinylcholine allows a more rapid
return of spontaneous respiration and airway reflexes,
which is very important in critical emergency patients
especially if difficult to ventilate or intubate (5, 18).
It was observed that the onset of action and duration
of action of succinylcholine were dose dependent (20).
Studies revealed or predicted when ventilation is not
assisted the possibility of life-threatening, profound
dropping of arterial oxygen saturation below 90% is
common with the high dose of 1 mg/kg due to prolonged
apnea time. It does not occur in low doses like 0.5 mg/kg
succinylcholine with short apnea time (19, 20). This is
augmenting the support for the small dose and indicates
that the recovery time is more important than the onset
of action especially in situations in which the health care
provider is less than certain of complete control of a
patient’s airway (21).
The duration of fasciculation of the anterior abdom-
inal wall in the study reflect a significant shorten in
duration B5 sec in 95% with a low dose (0.45 mg/kg),
compared to prolonged fasciculation duration in the high
common dose (1 mg/kg) 5:10 sec in 37% and  10 sec in
47% (prolonged in total of 84% with 1 mg/kg) (PB.001)
(Table 3). Reduction in fasciculation time gives the
advantage for use of low dose to reduced incidence of
an increase in intra-abdominal pressure, intra-gastric
pressure, and consequently minimizes the riskof vomiting
and aspiration in full stomach emergency patients (22).
The outcome of laryngoscopy and intubating condi-
tions with different doses in group 1, 2, and 3 revealed
easy intubation in 85.7%, 90%, and 94.7% and fair
intubation in 14.3%, 10%, and 5.3%, respectively.
Laryngoscopy outcome was 100% successfully accepted
in all patients in the three groups (Table 4). Tracheal
intubation condition, vocal cords movements/position,
and reaction to intubation (coughing and limb move-
ments) revealed excellent intubation in 85.7%, 90%, and
94.7% in group 1, 2, and 3, while good intubation in
Table 3. Onset time and durations of block and abdominal fasciculation
Succinylcholine dose
Variables
Group 1
0.45 mg/kg
Group 2
0.6 mg/kg
Group 3
1 mg/kg P-value
Onset time (second) 6592.5 5592.5 44.992.5 B0.001
Duration of block (minute) 590.6 6.490.8 12.591.3 B0.001
Duration of abdominal fasciculation:
B5 sec 20 (95.2%) 12 (60%) 3 (15.8%)
5:10 sec 1 (4.8%) 5 (25%) 7 (36.8%) B0.001
 10 sec 0 (0%) 3 (15%) 9 (47.4%)
Alaa Ezzat et al.
4
(page number not for citation purpose)
Citation: Libyan J Med 2011, 6: 7041 - DOI: 10.3402/ljm.v6i0.704114.3%, 10%, and 5.3%, respectively. Tracheal intubation
outcome was 100% successfully accepted in all patients in
the three groups (Table 4). There was no significant
difference in the outcome of laryngoscopy and intubating
conditions in the three groups (P.637). Naguib et al.
(8) found that in a dose of 1.0 mg/kg succinylcholine, it is
associated with an 80% incidence of excellent intubating
conditions and they recommended the use of 0.56 to
facilitate endotracheal intubation, which achieves accep-
table intubating conditions in 95% of well-prepared
ASA I & II patients. Therefore, use of 1 mg/kg may be
excessive if the goal is to achieve accepted intubation (8).
Other studies (2325) recorded the range of excel-
lent intubating conditions after the administration of
Table 4. Outcome of laryngoscopy and tracheal intubation
Succinylcholine dose
Variables
Group 1
0.45 mg/kg
Group 2
0.6 mg/kg
Group 3
1 mg/kg P-value
Laryngoscopy
Easy 18 (85.7%) 18 (90%) 18 (94.7%)
Fair 3 (14.3%) 2 (10%) 1 (5.3%) 0.637
Difficult  
Failed  
Vocal cords
Movements
None 18 (85.7%) 18 (90%) 18 (94.7%) 0.637
Moving 3 (14.3%) 2 (10%) 1 (5.3%)
Closed  
Closed  
Position
Abducted 18 (85.7%) 18 (90%) 18 (94.7%) 0.637
Intermediate 3 (14.3%) 2 (10%) 1 (5.3%)
Closed  
Closed  
Reaction to intubation:
Coughing
None 18 (85.7%) 18 (90%) 18 (94.7%) 0.637
Slight 3 (14.3%) 2 (10%) 1 (5.3%)
Vigorous  
Persistent  
Limb movements
None 18 (85.7%) 18 (90%) 18 (94.7%)
Mild 3 (14.3%) 2 (10%) 1 (5.3%) 0.637
Moderate  
Vigorous  
Intubation outcome
Excellent 18 (85.7%) 18 (90%) 18 (94.7%) 0.637
Good 3 (14.3%) 2 (10%) 1 (5.3%)
Poor  
Failed  
Acceptable
Excellent 18 (85.7%) 18 (90%) 18 (94.7%) 0.637
Good 3 (14.3%) 2 (10%) 1 (5.3%)
Unacceptable 0% 0% 0%
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induction in elective cases of 63% to 74%. It is a lower
incidence than those in our current study that dealt
with emergency critically ill cases (ASA III & IV).
The intubating conditions depend on several factors
including: the type and dose of inductive agents, the
depth of anesthesia, the interval between drug adminis-
tration and laryngoscopy, the dose of the neuromuscular
blocker given, the anatomy of the airways, and the
experience of the intubating person (4, 13).
Reducing the dose of succinylcholine (from 1 mg/kg
to 0.45 mg/kg) in emergency patients has numerous
clinical advantages. It minimizes the incidence of idio-
pathic malignant hyperthermia, myalgia, masseter spasm,
rhabdomyolysis, and hemodynamic changes (10). It
reduces the aggravated hyperkalemia in end-stage renal
failure, burn, and potassium sparing diuretics patients
(26). It avoids the excessive increase in intracranial
pressure in head injuries and minimizes the increase
in both intra-abdominal and intra-gastric pressures,
decreasing the incidences of vomiting and consequent
aspiration (10).
Conclusion
Succinylcholine in a dose of 0.45 mg/kg (1.5ED95)
compared with doses of 0.6 mg/kg (2ED95) and tradi-
tionally doses of 1 mg/kg ( 3ED95) was sufficient to
provide acceptable intubating conditions in 100% of the
patients. It shortens the duration of neuromuscular block
and abdominal fasciculation with non-clinical significant
delay in onset of action. Duration of action of succinyl-
choline is dose dependent, so reducing the dose allows a
more rapid return of spontaneous respiration and airway
reflexes. Thereby it decreases the window of vulnerability
in airway management during induction of anesthesia in
addition to reducing the incidence of succinylcholine-
induced side effects and complications. A succinylcholine
dose of 0.45 mg/kg provides an optimal intubation
condition in emergency ASA III & IV patients.
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